Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits.
It has been proposed that chemically reactive lipids released during lipid peroxidation convert low density lipoprotein (LDL), the major carrier of plasma cholesterol, to an abnormal form and that receptor-mediated clearance of this altered LDL produces cholesteryl ester deposition in macrophage-derived foam cells of atheroma. Immuno-cytochemical analyses now reveal the presence of protein modified by malondialdehyde, a peroxidative end product, which colocalizes with the extracellular deposition of apolipoprotein B-100 protein of LDL in atheroma from Watanabe heritable hyperlipidemic rabbits. These findings provide direct evidence for the existence in vivo of protein modified by a physiological product of lipid peroxidation within arterial lesions.
Haberland
M E
ME
Department of Medicine, UCLA School of Medicine 90024.
Fong
D
D
Cheng
L
L
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B / Q000378:metabolism*; D001161:Arteriosclerosis / Q000378:metabolism / Q000473:pathology*; D004195:Disease Models, Animal; D000939:Epitopes; D006949:Hyperlipidemias / Q000235:genetics / Q000473:pathology*; D008054:Lipid Peroxides; D008314:Malonates; D008315:Malondialdehyde; D011817:Rabbits
D000911:Antibodies, Monoclonal; D053299:Apolipoprotein B-100; D001055:Apolipoproteins B; D000939:Epitopes; D008054:Lipid Peroxides; D008314:Malonates; D008315:Malondialdehyde